Lucid, Inc.
US Elections Calendar ~ Pervez Musharraf ~ Iftikhar Muhammad Chaudhry ~ Other International News
Home / International News / Press Releases / March 24, 2008
Lucid's VivaScope(R) Reflective Confocal Microscope Approved for Sale in China

Top News

Andhra Pradesh Intermediate Results 2008

Chandrababu interacts with farmers who lost their crop in Guntur market fire

CEC to visit Dharwar to review poll preparations

Indian youth groups in Malaysia seek funds for education

Iron Man tops weekend box office with .5m

International conference on The New Business Laws Of India culminates into a grand debate

OJ Simpson confessed to agent about murdering wife

Intensive farming does well to conserve biodiversity

Restaurant smoking bans cut teens chances of becoming habitual smokers

Lucid's VivaScope(R) Reflective Confocal Microscope Approved for Sale in China

ROCHESTER, N.Y., March 24 /PRNewswire/ -- China's State Food and Drug Administration has approved the sale of the pioneering Lucid VivaScope(R) reflective confocal microscope in the Peoples Republic of China, said Jay Eastman, CEO of Lucid, a Rochester, New York-based medical device and information company dedicated to providing improved care for dermatology patients.

Lucid's VivaScope(R) reflective confocal microscopes (RCM) provide non- invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions -- without the need for surgery to excise tissue -- thus improving the quality of care for their patients.

"Just as MRI and CT scans have largely eliminated the need for routine 'exploratory surgery', the use of Lucid's VivaScope(R) confocal microscopes may one day eliminate the need for routine invasive skin biopsies," Eastman explained.

"This milestone announcement opens opportunities for application of confocal microscopes to evaluate and monitor treatment of skin inflammatory and pigmentation disorders with leading hospitals throughout China," Eastman said.

"I am very pleased to see this positive outcome from a long and detailed review process that will allow us to participate in one of the fastest growing medical markets in the world," he said. "We believe that reflectance confocal microscopes will become a standard clinical tool with its capacity to take painless, non-invasive optical biopsies of a wide range of skin lesions and disorders."

Sales of Lucid's VivaScope(R) confocal microscopes in China will be handled by ConBio (China) Co., Ltd, Eastman said.

Dr. Qiushi Ren, CEO, ConBio said, "We are excited by the opportunity to introduce Lucid's unique, leading RCM technology to Chinese doctors and building our business together."

Founded in 1996, ConBio is a multi-specialty health care company focused on providing innovative medical devices that enable people to live life to its greatest potential. ConBio has built strategic relationships with famous manufacturers in the dermatology, plastic and ophthalmologic fields around the world, including Lucid, Cutera, RA Medical, MedArt, Lutronic, Allergan, Schwind with a goal of becoming the leading provider of the advanced medical lasers, instruments and materials in China. ConBio has successfully sold more than 1,000 units of capital equipment to customers in China and prides itself on their after-sales service.

For information, visit Lucid's website at http://www.lucid-tech.com. Contact Lucid in China at ConBio (China) Co., Ltd., by email at qren@shanghai-conbio.com or by phone at: + 86 21 62720751. In the USA, contact Lucid by email at info@lucid-tech.com, or by phone at +1-585-239-9800.

About Lucid, Inc.

Lucid, Inc. (http://www.lucid-tech.com), based in Rochester, New York (USA) is a medical device and information company with offices in North America, Europe, and Australia. Lucid is dedicated to providing improved care for dermatology patients by coupling its noninvasive VivaScope(R) cellular imaging technology with its innovative VivaNet(R) medical information system to allow secure, HIPAA compliant, near real-time collaboration between dermatologists and other medical specialists. The VivaNet(R) system provides rapid online medical image transfer, storage, and retrieval thus enabling these critical collaborative consultations. The technologies delivered by Lucid provide images that physicians use in forming critical clinical judgments in cases of dermatologic disease, while ensuring patient comfort and piece of mind.

VivaNet(R) and VivaScope(R) are registered trademarks of Lucid, Inc.


Available Topic Expert(s): For information on the listed expert(s), click
appropriate link.
Jay Eastman, Ph.D.
http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=62055
Clifford Perlis
http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=74484

SOURCE Lucid, Inc.

International News / Press Release source: PR Newswire
Copyright PR Newswire. All Rights Reserved.

International Business News / Press Releases

WuXi PharmaTech (NYSE: WX) Honored Among the BCG 50 Local Dynamos
PR Newswire

Beijing Komoxo Mobile Software Licenses Patents From Microsoft
PR Newswire

The Conference Board(R) Australia Business Cycle Indicators(SM)
PR Newswire

Martin Froggatt to Succeed Paul Barry as President of Europe Express
PR Newswire

Boeing, Lion Air Celebrate 10th 737-900ER Delivery
PR Newswire

International Health News / Press Releases

WuXi PharmaTech (NYSE: WX) Honored Among the BCG 50 Local Dynamos
PR Newswire

Death Toll From Recalled Chinese Heparin Continues to Rise; Tainted Heparin Still in Circulation
PR Newswire

Hoya Announces Fourth Quarter and FY2007 Financial Results
PR Newswire

Lupin Announces Launch of Suprax(R) 400mg Tablets
PR Newswire

Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip
PR Newswire

International Medical News / Press Releases

WuXi PharmaTech (NYSE: WX) Honored Among the BCG 50 Local Dynamos
PR Newswire

Terumo, Global Medical Technology Company, Opens Office in Switzerland
PR Newswire

HeartWare Appoints David R. Hathaway, M.D. Chief Medical Officer
PR Newswire

Hoya Announces Fourth Quarter and FY2007 Financial Results
PR Newswire

Lupin Announces Launch of Suprax(R) 400mg Tablets
PR Newswire